Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Feb;32(1):10-17.
doi: 10.21147/j.issn.1000-9604.2020.01.02.

Incidence and mortality of laryngeal cancer in China, 2015

Yutong He  1 , Di Liang  1 , Daojuan Li  1 , Baoen Shan  1 , Rongshou Zheng  2 , Siwei Zhang  2 , Wenqiang Wei  2 , Jie He  2
Affiliations

Incidence and mortality of laryngeal cancer in China, 2015

Yutong He et al. Chin J Cancer Res. 2020 Feb.

Abstract

Objective: Using data from cancer registries to estimate laryngeal cancer incidence and mortality in China, 2015.

Methods: Data submitted from 501 cancer registries were checked and evaluated according to the criteria of data quality control and 368 registries' data were qualified for the final analysis. Data were stratified by area (urban/rural), sex, age group and combined with national population data to estimate laryngeal cancer incidence and mortality in China, 2015. China population census in 2000 and Segi's population were used for age-standardized.

Results: The percentage of cases morphological verified (MV%) of laryngeal cancer was 74.18%. The percentage of death certificate-only cases (DCO%) was 2.10%. And the mortality to incidence (M/I) ratio was 0.55. About 25,300 new cases of laryngeal cancer were diagnosed in 2015 and 13,700 deaths were reported. The crude rate of laryngeal cancer was 1.84 per 100,000 (males and females were 3.20 and 0.42 per 100,000, respectively). Age-standardized incidence rates by Chinese standard population (ASIRC) and by world standard population (ASIRW) were 1.18 and 1.19 per 100,000, respectively. The cumulative incidence rate (0-74 years old) was 0.15%. The crude mortality rate was 1.00 per 100,000. Age-standardized mortality rates by Chinese standard population (ASMRC) and by world standard population (ASMRW) were 0.61 and 0.61 per 100,000, respectively, with the cumulative rate (0-74 years old) was 0.07%. Incidence and mortality of laryngeal cancer in males were higher than those in females. And the rates in urban areas were higher than those in rural areas.

Conclusions: The incidence and mortality of laryngeal cancer in China were low. And the rates were significantly higher in males than in females. Risk factor control and targeted prevention should be strengthened.

Keywords: China; incidence; laryngeal cancer; mortality.

PubMed Disclaimer

Figures

1
1. Age-specific laryngeal cancer incidence rate in China, 2015.
2
2. Age-specific laryngeal cancer mortality rate in China, 2015.
See this image and copyright information in PMC

References

    1. van Dijk BA, Karim-Kos HE, Coebergh JW, et al Progress against laryngeal cancer in The Netherlands between 1989 and 2010. Int J Cancer. 2014;134:674–81. doi: 10.1002/ijc.28388. - DOI - PubMed
    1. GBD 2017 Disease and Injury Incidence and Prevalence Collaborators Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2018;392:1789–858. doi: 10.1016/S0140-6736(18)32279-7. - DOI - PMC - PubMed
    1. Bray F, Ferlay J, Soerjomataram I, et al Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA. 2018;68:394–424. doi: 10.3322/caac.21492. - DOI - PubMed

    1. National Cancer Center. Guideline for Chinese Cancer Regisitration. Beijing: People’s Medical Publishing House, 2016;59-75.

    1. Bray F, Parkin DM Evaluation of data quality in the cancer registry: principles and methods. Part I: comparability, validity and timeliness. Eur J Cancer. 2009;45:747–55. doi: 10.1016/j.ejca.2008.11.032. - DOI - PubMed

LinkOut - more resources